# Caroverin and Inner Ear Diseases

> **NCT01174979** · PHASE3 · SUSPENDED · sponsor: **Phafag AG** · enrollment: 170 (estimated)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** Caroverin

## Key facts

- **NCT ID:** NCT01174979
- **Lead sponsor:** Phafag AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2011-01
- **Primary completion:** 2015-08
- **Final completion:** —
- **Target enrollment:** 170 (ESTIMATED)
- **Why stopped:** due to less patient the study was suspended
- **Last updated:** 2015-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174979, "Caroverin and Inner Ear Diseases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01174979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*